ヒトの寿命の遺伝率は約50% - ただし遺伝率の定義を別のものに再定義した場合
この記事では、ヒトの寿命の遺伝率が約50%であるという研究結果について論じています。ただし、これは従来の遺伝率の定義とは異なる新しい定義に基づいた数値であり、遺伝率の概念を再定義することで得られた見解です。
関連記事
The article examines the field of longevity research, focusing on Altos Labs and cellular rejuvenation. While acknowledging widespread hype around anti-aging breakthroughs, it details serious scientific work on biological reprogramming that could fundamentally extend human healthspan, distinguishing genuine advances from exaggerated claims.
The article examines the growing field of cellular rejuvenation research, particularly work at Altos Labs, which aims to reverse biological aging at the cellular level. While acknowledging that much longevity science is overhyped, it highlights that this line of research could fundamentally reshape medicine and human healthspan if it succeeds.
Researchers have discovered unexpected cancer-like mutations in the brain's immune cells that may contribute to Alzheimer's disease progression. These mutations occur in microglia cells and appear to drive inflammation and neurodegeneration. The findings suggest new potential therapeutic targets for Alzheimer's treatment.
The prevalence of dementia at given ages has decreased compared to decades ago. Today's 90-year-olds have less than half the dementia risk compared to those in 1984.
The article explores the growing interest among wealthy and powerful individuals in longevity and life-extension technologies, examining the ethical and societal implications if such breakthroughs become accessible only to a select few.